India struggling to vaccinate with supply shortage, despite export ban

Posted on May 6, 2021

Vaccination rates in India starting increasing in March, with a further increase shortly after the export ban was imposed. However, though a ban on exports of the AstraZeneca vaccine was placed on 24th March to address supply issues, India is still struggling to meet the demand, with supply still being a limiting factor in their vaccination campaign, seen in the graph where total vaccinations match supply. Furthermore, it can then be seen that the rate of vaccination begins to slow.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022